IP Group plc is the most active UK based, early-stage science investor, having formed more than 600 science-based businesses. Backing companies from start-up to scale-up, the Group develops and supports some of the world’s most exciting businesses in deeptech, healthtech and cleantech.

IP Group pioneered systematic university spin out investment 25 years ago and is now the largest investor in UK university spin outs, alongside Parkwalk, our EIS fund management business. The Group benefits from deep partnerships with leading research institutions, including the University of Oxford, the University of Cambridge, and Imperial College London, providing access to a pipeline of pioneering scientific research and IP. The Group also works closely with other university specific or ‘regional cluster’ market participants such as Northern Gritstone, for whom it manages the Northern Universities Venture Fund. In Australia, IP Group partners with the Group of Eight and the University of Auckland.

IP Group’s specialist investment team combines sector expertise with an international approach and has a long track record of supporting standout companies such as Oxford Nanopore Technologies plc, Hinge Health, Featurespace, Ceres Power plc, Hysata, and Oxa.

IP Group supports its portfolio companies with capital from its own balance sheet leveraged with capital managed on behalf of others, as well as capital from its network of co-investors. IP Group manages over £0.5bn of third party capital, including a mandate for Hostplus, one of Australia’s top ten superannuation funds. The Group has also launched the IP Group Climate Catalyst Fund with Australia’s Clean Energy Finance Corporation and works with Aberdeen in the UK to manage a portfolio of early-stage and growth investments in the UK as part of a private asset solution.

IP Group is listed on the Main Market of the London Stock Exchange under the code IPO. For more information, please visit the IP Group website - www.ipgroupplc.com.

JPMorgan Japanese (JFJ) seeks to tap into the long-term story of Japan’s structural economic transformation by investing in high-quality innovative companies in sectors such as robotics, materials, healthcare, e-commerce and business services, as well as companies transitioning to more capital efficient business models. JFJ, one of the largest and oldest closed-end funds focused on Japanese equities, is managed locally and supported by a team of over 25 specialist investment professionals in Tokyo. JFJ is managed with an unconstrained investment approach to deliver a high conviction, high-quality and growth-focused portfolio, investing in companies of all sizes.

Emily Whiting, managing director, is a Investment Specialist within the Emerging Markets and Asia Pacific (EMAP) Equities team, based in London. An employee since 2005, Emily previously worked in the London Request for Proposal Group, specialising in Far East and Emerging Markets equity products.  Emily obtained a B.Sc in Money, Banking and Finance from the University of Birmingham

The Company seeks to provide investors with an attractive level of income and the potential for capital growth, becoming the REIT of choice for private and institutional investors seeking high and stable dividends from well-diversified UK real estate.

Custodian Property Income REIT offers investors the opportunity to access a diversified portfolio of UK commercial real estate through a closed-ended fund. The Company seeks to deliver a higher level of fully covered dividend by pursuing a smaller regional property strategy. We believe, through this strategy, it is possible to secure a marginal income advantage, without adding to property specific risk or concentration risk. Our diverse portfolio consists of properties let to institutional-grade tenants on long leases throughout the UK.